Tucatinib in patients with locally advanced or metastatic her2+++ breast cancer who received at least two prior anti-her2 treatment regimens: study design of the non-interventional study trace in germany and austria

Nadia Harbeck,Rupert Bartsch,Volkmar Mueller,Marija Balic,Daniel Egle,Eva Schumacher-Wulf, Moritz Angerer,Arnd Nusch, Christoph Uleer,Manfred Welslau,Julia Radosa, Denise Wrobel, Rebecca De Buhr, Martin Glasstetter, Johanna Hanselmann,Cathrin Hogrefe,Norbert Marschner, Katja Gratzke,Anja Welt

ANTICANCER RESEARCH(2023)

引用 0|浏览9
暂无评分
关键词
HER2+++ breast cancer, ABC, anti-HER2 treatment, non-interventional, real-world, tucatinib, Germany, Austria
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要